Occult Hepatitis C Virus Infection and Its Relevance in Clinical Practice

Journal of Clinical and Experimental Hepatology

Volumn 1, Issue 3, 2011, Pages 185-189

  Pham, Tram N Q ^a   Michalak, Tomasz I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Clinical practice; Hepatitis C; Identification of OCI; Occult HCV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DRUG RESPONSE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; NUCLEIC ACID AMPLIFICATION; OCCULT HEPATITIS C; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUSTAINED VIROLOGICAL RESPONSE; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 84856900402     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/S0973-6883(11)60130-8     Document Type: Article

References (45)

1. Alberti A, Chemello L, Benvegnu L Natural history of hepatitis C. J Hepatol 1999, 31:17-24.
2. Blackard JT, Kemmer N, Sherman KE Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006, 44:15-22.
3. Lerat H, Rumin S, Habersetzer F, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998, 91:3841-3849.
4. Pal S, Sullivan DG, Kim S, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006, 130:1107-1116.
5. Pham TN, King D, MacParland SA, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008, 134:812-822.
6. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992, 15:382-386.
7. MacParland SA, Pham TN, Gujar SA, Michalak TI De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006, 87:3577-3586.
8. MacParland SA, Pham TN, Guy CS, Michalak TI Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 2009, 49:1431-1441.
9. Kondo Y, Sung VM, Machida K, Liu M, Lai MM Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 2007, 361:161-173.
10. Morsica G, Tambussi G, Sitia G, et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 1999, 94:1138-1139.
11. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006, 43:1277-1283.
12. Ciancio A, Smedile A, Giordanino C, et al. Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?. Am J Gastroenterol 2006, 101:1811-1816.
13. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004, 78:5867-5874.
14. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005, 41:106-114.
15. Castillo I, Pardo M, Bartolome J, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004, 189:7-14.
16. George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009, 49:729-738.
17. Maylin S, Martinot-Peignoux M, Ripault MP, et al. Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver Int 2009, 29:511-517.
18. Nicot F, Kamar N, Mariame B, Rostaing L, Pasquier C, Izopet J No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transpl Int 2010, 23:594-601.
19. Halfon P, Bourliere M, Ouzan D, et al. Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 2008, 46:2106-2108.
20. Bokharaei-Salim F, Keyvani H, Monavari SH, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol 2011, 83:989-995.
21. Zaghloul H, El Sherbiny W Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest 2010, 39:284-291.
22. Pham TN, Coffin CS, Michalak TI Occult hepatitis C virus infection: what does it mean?. Liver Int 2010, 30:502-511.
23. Pham TN, Coffin CS, Churchill ND, Urbanski SJ, Lee SS, Michalak TI Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus. J Viral Hepat 2011, (published online March 1, 2011).
24. Pham TN, MacParland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005, 86:657-666.
25. Di Liberto G, Roque-Afonso AM, Kara R, et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006, 131:76-84.
26. Ducoulombier D, Roque-Afonso AM, Di Liberto G, et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004, 39:817-825.
27. Coppola N, Pisaturo M, Guastafierro S, et al. Absence of occult HCV infection in patients under immunosuppressive therapy for oncohematological diseases. Hepatology 2011, 54:1487-1489.
28. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection. Aliment Pharmacol Ther 2009, 30:477-486.
29. Germer JJ, Zein NN Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 2001, 76:911-920.
30. Formann E, Steindl-Munda P, Hofer H, et al. Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther 2006, 23:507-511.
31. Berasain C, Betes M, Panizo A, et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000, 47:429-435.
32. Hoare M, Gelson WT, Rushbrook SM, et al. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology 2008, 48:1737-1745.
33. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998, 28:823-830.
34. Lee WM, Poison JE, Carney DS, Sahin B, Gale M Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005, 192:1088-1092.
35. Lin A, Thadareddy A, Goldstein MJ, Lake-Bakaar G Immune suppression leading to hepatitis C virus re-emergence after sustained virological response. J Med Virol 2008, 80:1720-1722.
36. Nudo CG, Cortes RA, Weppler D, Schiff ER, Tzakis AG, Regev A Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome. Transplant Proc 2008, 40:1449-1455.
37. Thomopoulos K, Giannakoulas NC, Tsamandas AC, et al. Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment. Am J Med Sci 2008, 336:73-76.
38. Kobayashi S, Takeda T, Enomoto M, et al. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients. Liver Int 2007, 27:186-191.
39. Makiyama A, Itoh Y, Kasahara A, et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 2004, 101:1616-1622.
40. Veldt BJ, Saracco G, Boyer N, et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004, 53:1504-1508.
41. Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007, 147:677-684.
42. Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001, 34:809-816.
43. Casato M, Lilli D, Donato G, et al. Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat 2003, 10:455-459.
44. Pardo M, Castillo I, Arenas MD, et al. Antiviral therapy in patients with occult HCV infection. Hepatology 2005, 42:658A.
45. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008, 49:652-657.